Informação sobre produto
- (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid
- (2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-Carboxy-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name)
- Cyclopenta[b]pyrrole-2-carboxylic acid, 1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]-1-oxopropyl]octahydro-, (2S,3aS,6aS)-
- Cyclopenta[b]pyrrole-2-carboxylic acid, 1-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]octahydro-, [2S-[1[R*(R*)],2α,3aβ,6aβ]]-
- HOE 498 diacid
- Ramipril diacid
- Ramiprilate
Ramiprilat is an angiotensin-converting enzyme inhibitor that is used to treat high blood pressure and congestive heart failure. It binds to the active site of the enzyme and blocks its activity, inhibiting the formation of angiotensin II. Ramiprilat reduces matrix metalloproteinase (MMP)-9 activity in human polymorphonuclear leukocytes, which may be due to its inhibitory properties on MMP-9 synthesis. This drug has been shown to decrease the rate of myocardial infarction in patients with left ventricular dysfunction.
Propriedades químicas
Consulta técnica sobre: 3D-FR27678 Ramiprilat
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
